Literature DB >> 17006932

Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas.

Jian-Hua Luo1, Baoguo Ren, Sergei Keryanov, George C Tseng, Uma N M Rao, Satdarshan P Monga, Steven Strom, Anthony J Demetris, Michael Nalesnik, Yan P Yu, Sarangarajan Ranganathan, George K Michalopoulos.   

Abstract

This study analyzed gene expression patterns and global genomic alterations in hepatocellular carcinomas (HCC), hepatoblastomas (HPBL), tissue adjacent to HCC and normal liver tissue derived from normal livers and hepatic resections. We found that HCC and adjacent non-neoplastic cirrhotic tissue have considerable overlap in gene expression patterns compared to normal liver. Several genes including Glypican 3, spondin-2, PEG10, EDIL3 and Osteopontin are over-expressed in HCC vs. adjacent tissue whereas Ficolin 3 is the most consistently under-expressed gene. HCC can be subdivided into three clusters based on gene expression patterns. HCC and HPBL have clearly different patterns of gene expression, with genes IGF2, Fibronectin, DLK1, TGFb1, MALAT1 and MIG6 being over-expressed in HPBL versus HCC. In addition, specific areas of the genome appear unstable in HCC, with the same regions undergoing either deletion or increased gene dosage in all HCC. In conclusion, a set of specific genes and areas of genomic instability are found across the board in liver neoplasia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006932      PMCID: PMC1769554          DOI: 10.1002/hep.21328

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

Review 1.  Cellular origin of hepatocellular carcinomas.

Authors:  Stewart Sell
Journal:  Semin Cell Dev Biol       Date:  2002-12       Impact factor: 7.727

Review 2.  Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets.

Authors:  Ju-Seog Lee; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

3.  Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.

Authors:  Mariana Capurro; Ian R Wanless; Morris Sherman; Gerrit Deboer; Wen Shi; Eiji Miyoshi; Jorge Filmus
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

4.  Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

Authors:  Tetsuya Nakatsura; Yoshihiro Yoshitake; Satoru Senju; Mikio Monji; Hiroyuki Komori; Yutaka Motomura; Seiji Hosaka; Toru Beppu; Takatoshi Ishiko; Hidenobu Kamohara; Hiroshi Ashihara; Toyomasa Katagiri; Yoichi Furukawa; Shigetoshi Fujiyama; Michio Ogawa; Yusuke Nakamura; Yasuharu Nishimura
Journal:  Biochem Biophys Res Commun       Date:  2003-06-20       Impact factor: 3.575

5.  Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers.

Authors:  Ann-Ping Tsou; Yu-Chi Chuang; Jin-Yuan Su; Chu-Wen Yang; Yu-Lun Liao; Wei-Kuang Liu; Jen-Hwey Chiu; Chen-Kung Chou
Journal:  J Biomed Sci       Date:  2003       Impact factor: 8.410

6.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

Authors:  Ju-Seog Lee; In-Sun Chu; Jeonghoon Heo; Diego F Calvisi; Zongtang Sun; Tania Roskams; Anne Durnez; Anthony J Demetris; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

7.  CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma.

Authors:  Kazuhiro Hirohashi; Takatsugu Yamamoto; Takahiro Uenishi; Masao Ogawa; Katsu Sakabe; Shigekazu Takemura; Taichi Shuto; Hiromu Tanaka; Shoji Kubo; Hiroaki Kinoshita
Journal:  Hepatogastroenterology       Date:  2004 Jul-Aug

8.  Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.

Authors:  Hiroshi Okabe; Seiji Satoh; Yoichi Furukawa; Tatsushi Kato; Suguru Hasegawa; Yumi Nakajima; Yoshio Yamaoka; Yusuke Nakamura
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  Glypican-3 is overexpressed in human hepatocellular carcinoma.

Authors:  Young Kwan Sung; Sun Young Hwang; Mi Kyung Park; Mohammad Farooq; In Sook Han; Han Ik Bae; Jung-Chul Kim; Moonkyu Kim
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

10.  Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1.

Authors:  Charlotte Harken Jensen; Eva Irene Jauho; Eric Santoni-Rugiu; Uffe Holmskov; Børge Teisner; Niels Tygstrup; Hanne Cathrine Bisgaard
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more
  141 in total

Review 1.  Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression.

Authors:  Keith T Gagnon; David R Corey
Journal:  Nucleic Acid Ther       Date:  2012-01-27       Impact factor: 5.486

2.  Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation.

Authors:  Michael A Nalesnik; George Tseng; Ying Ding; Guo-Sheng Xiang; Zhong-liang Zheng; YanPing Yu; James W Marsh; George K Michalopoulos; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-02-08       Impact factor: 4.307

3.  High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients.

Authors:  Jian-Cong Sun; Xiao-Ting Liang; Ke Pan; Hui Wang; Jing-Jing Zhao; Jian-Jun Li; Hai-Qing Ma; Yi-Bing Chen; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 4.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

5.  Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Authors:  Lei Nie; Hsing-Ju Wu; Jung-Mao Hsu; Shih-Shin Chang; Adam M Labaff; Chia-Wei Li; Yan Wang; Jennifer L Hsu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2012-04-08       Impact factor: 4.060

Review 6.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 7.  Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

Authors:  George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.

Authors:  Er-Jun Pang; Rui Yang; Xi-bo Fu; Ye-fu Liu
Journal:  Tumour Biol       Date:  2014-12-08

Review 9.  MALAT1 -- a paradigm for long noncoding RNA function in cancer.

Authors:  Tony Gutschner; Monika Hämmerle; Sven Diederichs
Journal:  J Mol Med (Berl)       Date:  2013-03-26       Impact factor: 4.599

10.  Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer.

Authors:  Shou-Ping Xu; Jin-Feng Zhang; Shi-Yao Sui; Nan-Xia Bai; Song Gao; Guang-Wen Zhang; Qing-Yu Shi; Zi-Long You; Chao Zhan; Da Pang
Journal:  Tumour Biol       Date:  2015-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.